FOI release

Freedom of Information responses from the MHRA - week commencing 6 December 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 6 December 2021

• From: Medicines and Healthcare products Regulatory Agency
• Published: 31 May 2022

Documents

Freedom of Information request on the regulatory approval of the COVID-19 Pfizer vaccine (FOI 21/1241)

HTML

Freedom of Information request on all emails sent or received by the head of the MHRA's Biologicals Unit since the start of the COVID-19 pandemic for Novavax , Novavax, NVX-CoV2373 and Nuvaxovid (FOI 21/1243)

HTML

Freedom of Information request on the MHRA contracts register (FOI 21/1257)

HTML

Freedom of Information request on the Drug Analysis Print (DAP) for the Fluenz Tetra vaccine (FOI 21/1272)

HTML

FOI-21-1272-1

PDF, 69.7 KB, 35 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI-21-1272-2

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on the current progress of the COVID-19 Novavax vaccine (FOI 21/1274)

HTML

Freedom of Information request on the efficacy and safety data regarding COVID-19 vaccines (FOI 21/1246)

HTML

Freedom of Information request on the safety of COVID-19 vaccines and pregnancies (FOI 21/1250)

HTML

Freedom of Information request on the clinical trials data showing phenomenon of antigenic imprinting (FOI 21/1275)

HTML

Freedom of Information request on the documents related to those who never received COVID-19 vaccine and those who had COVID-19 once and were re-infected and then transmitted SARS-CoV-2 (FOI/1281)

HTML

Freedom of Information request on correspondence within the MHRA regarding the regulation of COVID-19 testing labs in relation to Randox since January 2020 (FOI 21/1204)

HTML

Freedom of Information request on Paediatric Investigation Plan for molnupiravir (FOI 21/1205)

HTML

Freedom of Information request on the regulatory approval on the COVID-19 vaccines (FOI 21/1242)

HTML

Freedom of Information request on the death's reported following the COVID-19 vaccines (FOI 21/1216)

HTML

Freedom of Information request on the total number of Yellow Card reports to date since 2021 (FOI 21/1219)

HTML

Freedom of Information request on the Drug Analysis Prints for the 4 in 1 child booster shots and MMR vaccinations (FOI 21/1223)

HTML

FOI-21-1223-1

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI-21-1223-2

PDF, 50.3 KB, 28 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI-21-1223-3

PDF, 113 KB, 50 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on the MHRA IT security strategy (FOI 21/1270)

HTML

Freedom of Information request on the relation to causing suicidal ideation and behaviour (FOI 21/1210)

HTML

Freedom of Information request on the Risk Management Plan for Sodium Bicarbonate 500 mg Capsules, Clonazepam 0.5mg & 2mg Tablets and Naprosyn 250mg and 500mg Tablets (FOI 21/1283)

HTML

Freedom of Information request on applications submitted for Trabectedin in the last six months (FOI 21/1285)

HTML

Freedom of Information request on the Public Assessment Report for Cibinqo 50, 100 & 200 mg film-coated tablets (FOI 21/1211)

HTML

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 6 December 2021

Published 31 May 2022